Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children’s Oncology Group

PURPOSE: To investigate whether event-free survival (EFS) can be maintained among children and adolescents with intermediate-risk (IR) malignant germ cell tumors (MGCT) if the administration of cisplatin, etoposide, and bleomycin (PEb) is reduced from four to three cycles and compressed from 5 to 3...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Oncol
Huvudupphovsmän: Shaikh, Furqan, Cullen, John W., Olson, Thomas A., Pashankar, Farzana, Malogolowkin, Marcio H., Amatruda, James F., Villaluna, Doojduen, Krailo, Mark, Billmire, Deborah F., Rescorla, Frederick J., Egler, Rachel A., Dicken, Bryan J., Ross, Jonathan H., Schlatter, Marc, Rodriguez-Galindo, Carlos, Frazier, A. Lindsay
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Clinical Oncology 2017
Ämnen:
ORIGINAL REPORTS
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455599/
https://ncbi.nlm.nih.gov/pubmed/28240974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.6544
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk